M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
IXICO's AI platform validated in Huntington's Disease research
Neuroscience imaging company IXICO plc (AIM: IXI) announced on Wednesday that it has further validated its AI-driven analysis platform, IXIQ.Ai, through collaboration with the Huntington's Disease Imaging Harmonisation (HD-IH) consortium. The breakthrough reinforces IXICO's position in...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search